Grant: Discovery Grants Program - Individual
Dalhousie University
$30,000.00
Elucidation of Pathways: Bacterial and Mass Spectrometric Studies
EF 2016-17
Résumé
Bacteria are intimately associated with the human body; beneficial bacteria support health and well-being by aiding digestion, protecting against infection, and stimulating the immune system. Substances produced by bacteria, known as metabolites, act as molecular signals defining the bacterium-host relationship. To potentially benefit the quality of life by revealing new directions for the treatment of disease, our approach is to thoroughly study Fusobacterium varium, a bacterium typically found in the intestines of animals that may contribute to the initiation of bowel disease.
Our research program also focuses on chemical processes associated with mass spectrometry, a technique in which molecules are first charged and then broken into pieces upon input of energy. The specific pieces formed are diagnostic, providing a basis for the identification of drugs, environmental contaminants and explosives in various situations and allowing conclusions to be drawn that have broad implications (e.g., the use of banned substances in sports). To develop a deeper understanding of fundamentals behind these important applications, we choose substances that mimic the structures of current drugs and drug candidates, and can accommodate charge in more than one location, increasing their likelihood to break apart in two or more different ways (i.e., fragmentation pathways). With our interpretative developments, mass spectrometry will provide enriched and more reliable information, increasing its value as an essential tool for the characterization of drug metabolites and shortening the time needed to complete this essential step in the development of prospective new drugs.
As a complement to genetic studies, our on-going chemical research has demonstrated metabolic diversity in the intestinal bacterium leading to the production of eight substances, of which one may have an unanticipated function as a molecular signal with implications in bowel disease. By identifying the pathways used to form these metabolites, unique metabolic processes in anaerobic bacteria can be evaluated as targets for selective metabolic inhibitors, a novel rational design strategy for the generation of lead compounds for novel antibiotics effective against pathogenic bacteria resistant to current antibiotic treatments. Also, three of the bacterial metabolites excreted have important practical applications as sustainable chemical feed stocks used, for example, in the manufacture of biodegradable polymers with biomedical applications.
In this application, funding is requested to pursue two seemingly diverse research investigations. However, commonalities in the thought process of our mechanistic investigative approach to pathway elucidation and the nature of the substances studied provide significant overlap. For each, we design and synthesize probes to test pathway hypotheses, collect evidence using substances labelled with stable isotopes, and logically assimilate the evidence to provide a reliable description of each pathway. Overall, we tackle fundamental questions in the relationship between intestinal bacteria and human hosts, a complex and relatively unexplored area at the intersection of bacterium and human metabolism. Our research program in fundamental science will offer new insights for the interpretation and application of important sequential consecutive chemical processes, the implementation of sustainable fermentation methods, and potentially new avenues of drug research and discovery.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2014-04536
Name nom
White, Robert
Department département
Chemistry
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2014
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
3
Nb partie
5
Application title
Elucidation of Pathways: Bacterial and Mass Spectrometric Studies
Keyword
NSERC
Application summary
Bacteria are intimately associated with the human body; beneficial bacteria support health and well-being by aiding digestion, protecting against infection, and stimulating the immune system. Substances produced by bacteria, known as metabolites, act as molecular signals defining the bacterium-host relationship. To potentially benefit the quality of life by revealing new directions for the treatment of disease, our approach is to thoroughly study Fusobacterium varium, a bacterium typically found in the intestines of animals that may contribute to the initiation of bowel disease.
Our research program also focuses on chemical processes associated with mass spectrometry, a technique in which molecules are first charged and then broken into pieces upon input of energy. The specific pieces formed are diagnostic, providing a basis for the identification of drugs, environmental contaminants and explosives in various situations and allowing conclusions to be drawn that have broad implications (e.g., the use of banned substances in sports). To develop a deeper understanding of fundamentals behind these important applications, we choose substances that mimic the structures of current drugs and drug candidates, and can accommodate charge in more than one location, increasing their likelihood to break apart in two or more different ways (i.e., fragmentation pathways). With our interpretative developments, mass spectrometry will provide enriched and more reliable information, increasing its value as an essential tool for the characterization of drug metabolites and shortening the time needed to complete this essential step in the development of prospective new drugs.
As a complement to genetic studies, our on-going chemical research has demonstrated metabolic diversity in the intestinal bacterium leading to the production of eight substances, of which one may have an unanticipated function as a molecular signal with implications in bowel disease. By identifying the pathways used to form these metabolites, unique metabolic processes in anaerobic bacteria can be evaluated as targets for selective metabolic inhibitors, a novel rational design strategy for the generation of lead compounds for novel antibiotics effective against pathogenic bacteria resistant to current antibiotic treatments. Also, three of the bacterial metabolites excreted have important practical applications as sustainable chemical feed stocks used, for example, in the manufacture of biodegradable polymers with biomedical applications.
In this application, funding is requested to pursue two seemingly diverse research investigations. However, commonalities in the thought process of our mechanistic investigative approach to pathway elucidation and the nature of the substances studied provide significant overlap. For each, we design and synthesize probes to test pathway hypotheses, collect evidence using substances labelled with stable isotopes, and logically assimilate the evidence to provide a reliable description of each pathway. Overall, we tackle fundamental questions in the relationship between intestinal bacteria and human hosts, a complex and relatively unexplored area at the intersection of bacterium and human metabolism. Our research program in fundamental science will offer new insights for the interpretation and application of important sequential consecutive chemical processes, the implementation of sustainable fermentation methods, and potentially new avenues of drug research and discovery.